Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland.
Histol Histopathol. 2011 Apr;26(4):443-9. doi: 10.14670/HH-26.443.
Snail1, a key regulator of epithelial-mesenchymal transition (EMT), plays an important role in tumour progression. Previous studies of snail1 have mainly focused on the epithelial tumour cells. The objective of this study was to evaluate the expression of snail1 protein in endothelial cells, stromal myofibroblasts and malignant epithelial cells of pharyngeal squamous cell carcinomas (PSCC), as well as its relation to clinicopathological features and survival. One hundred and ten tissue microarray samples were analyzed for snail1 expression using immunohistochemistry. In endothelial cells snail1 expression was observed in 51 (48%) of 107 cases and it predicted reduced disease specific survival (DSS) (p=0.009). In 49 (46%) tumour samples snail1 immunostaining was detected in stromal myofibroblasts and there was a tendency to poorer DSS in that group (p=0.067). Snail1 expression in endothelial cells and stromal myofibroblasts is also associated with hypopharyngeal tumours (p=0.01 and p=0.038 respectively), increasing T category (T3-4) (p=0.005, p=0.037 respectively) and poorer general condition of the patient (Karnofsky performance status score <70; p=0.029, p=0.039 respectively). Moreover endothelial expression correlated with advanced stage (III-IV) (p=0.005) and poorer differentiation (grade 2-3; p=0.012). In malignant epithelial cells snail1 immunostaining was detected in 75 of 110 cases (68%). Expression of the protein was more common in hypopharyngeal tumours (p=0.044). Snail1 positive tumours associated with a lower Karnofsky performance status score (p=0.039) and regional failure (p=0.042). Our findings indicate that snail1 protein expression in endothelial cells and to some extent also in tumour stromal myofibroblasts seems to be a predictor of poor survival in PSCC. The presence of snail1 protein in tumour microenvironment rather than in malignant epithelial tumour cells may induce tissue remodelling and tumour progression.
蜗牛 1 是上皮间质转化 (EMT) 的关键调节因子,在肿瘤进展中发挥重要作用。以前对蜗牛 1 的研究主要集中在上皮肿瘤细胞上。本研究旨在评估蜗牛 1 蛋白在咽鳞癌 (PSCC) 的内皮细胞、基质成肌纤维细胞和恶性上皮细胞中的表达及其与临床病理特征和生存的关系。使用免疫组织化学方法分析了 110 个组织微阵列样本中的蜗牛 1 表达。在内皮细胞中,在 107 例中的 51 例 (48%) 观察到蜗牛 1 表达,其预测疾病特异性生存 (DSS) 降低 (p=0.009)。在 49 例 (46%) 肿瘤样本中检测到基质成肌纤维细胞中的蜗牛 1 免疫染色,该组 DSS 较差的趋势 (p=0.067)。内皮细胞和基质成肌纤维细胞中蜗牛 1 的表达也与下咽肿瘤有关 (p=0.01 和 p=0.038 分别),T 期增加 (T3-4) (p=0.005,p=0.037 分别) 和患者一般状况较差 (卡氏行为状态评分<70; p=0.029,p=0.039 分别)。此外,内皮细胞的表达与晚期 (III-IV) 相关 (p=0.005) 和分化较差 (2-3 级;p=0.012)。在 110 例中有 75 例检测到恶性上皮细胞中的蜗牛 1 免疫染色。该蛋白的表达在上咽肿瘤中更为常见 (p=0.044)。蜗牛 1 阳性肿瘤与较低的卡氏行为状态评分 (p=0.039) 和区域失败 (p=0.042) 相关。我们的研究结果表明,内皮细胞中的蜗牛 1 蛋白表达,在一定程度上也存在于肿瘤基质成肌纤维细胞中,似乎是 PSCC 生存不良的预测指标。肿瘤微环境中蜗牛 1 蛋白的存在而不是恶性上皮肿瘤细胞中的存在可能会诱导组织重塑和肿瘤进展。